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Available online 14 January 2017Parents are often uncertain about the vaccination status of their children. In times of vaccine hesitancy, vaccina-
tion programs could benefit from active patient participation. The Vaccination App (VAccApp) was developed by
the Vienna Vaccine Safety Initiative, enabling parents to learn about the vaccination status of their children, in-
cluding 25 different routine, special indication and travel vaccines listed in the WHO Immunization Certificate
of Vaccination (WHO-ICV). Between 2012 and 2014, the VAccAppwas validated in a hospital-based quality man-
agement program in Berlin, Germany, in collaboration with the Robert Koch Institute. Parents of 178 children
were asked to transfer the immunization data of their children from theWHO-ICV into the VAccApp. The respec-
tive WHO-ICV was photocopied for independent, professional data entry (gold standard). Demonstrating the
status quo in vaccine information reporting, a Recall Group of 278 parents underwent structured interviews for
verbal immunization histories, without the respective WHO-ICV. Only 9% of the Recall Group were able to
provide a complete vaccination status; on average 39% of the questions were answered correctly. Using the
WHO-ICV with the help of the VAccApp resulted in 62% of parents providing a complete vaccination status; on
average 95% of the questions were answered correctly. After using the VAccApp, parents were more likely to
remember key aspects of the vaccination history. User-friendly mobile applications empower parents to take a
closer look at the vaccination record, thereby taking an active role in providing accurate vaccination histories.
Parents may become motivated to ask informed questions and to keep vaccinations up-to-date.
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The World Health Organization (WHO) recommends that each pa-
tient-physician encounter should be utilized to determine the patient'sdard operating procedure; QM,
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nc. This is an open access article undvaccination status (Robert Koch Institute, 2014; Hutchins et al., 1993).
In an effort to harmonize vaccination records for international travel,
theWHOhas issued the International Certificate of Vaccination or Prophy-
laxis (WHO-ICV), sometimes referred to as “the yellow card” (World
Health Organization, 2005).
In many European countries, centralized vaccination registries are
not available, but parents are maintaining a paper-based vaccination
record for their children at home (UNICEF, 2016). In Germany, the
WHO-ICV is used as the standard vaccination record, where any routine,
special indication and travel vaccines are documented (UNICEF, 2016;
National VaccineAdvisory Committee, 2003). Parents rushing their chil-
dren to the emergency department (ED) however, often forget to bring
theWHO-ICV with them (Goldstein et al., 1993). Pediatricians and sur-
geons may require the information in the acute care situation (Macken
et al., 2013; Brown, 2012). In these instances, the parents will be asked
to remember which vaccines have been administered to their childrener the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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during verbal immunization histories is that the children have received
“the usual vaccines”. Further details are often inaccessible (Miles et al.,
2013).
The European Centre for Disease Prevention and Control (ECDC) as
well as the VENICE project keep track on vaccination rates in different
EU member states (VENICE II Consortium, 2012; Lopalco and Carrillo,
2014). According to ECDC, German vaccination rates are lower than in
many other European countries (VENICE II Consortium, 2011). A recent
global survey of vaccine acceptance around the world revealed that Eu-
rope is in fact the WHO region with the lowest vaccine acceptance
(Larson et al., 2016). Germany is one of the countries with significant is-
sues in this area. As a result, vaccine-preventable diseases (VPD) are still
posing a health risk to children in Germany today. For example, the
prevalence of measles infections remained high during the past decade,
despite the universal recommendation and availability of measles vac-
cines (Neuhauser et al., 2014). Disease outbreaks are the consequence
(Robert Koch Institute, 2016; Opel et al., 2014).
The combat against VPD would benefit from empowered parents,
who are able to provide detailed and accurate vaccination histories
and who are in a position to interpret what has been documented in
the vaccination record (Sabnis et al., 2003). Scientific studies assessing
the ability of lay people to understand and report the content of a
WHO-ICV however, are lacking (Maurer et al., 2014).
To enable parents to report accurate vaccination histories, the Vien-
naVaccine Safety Initiative (ViVI) has developed a digital vaccine educa-
tion and empowerment tool (VAccApp) to be used on smartphones or
tablet computers (MacFadyen, 2014; Norman and Yip, 2012; Seeber et
al., 2015). The VAccApp was designed to invite parents to take a look
at theWHO-ICV and to engage in a virtual dialogue covering all aspects
of vaccines administered to their children, thereby making parents an
active partner in protecting their family. The development of this educa-
tional intervention was informed by the data gathered from a separate
group of parents, who tried to remember the vaccination status of
their child in the absence of a vaccination record (“Recall Group”).
The verbal immunization histories generated awareness of knowl-
edge gaps among parents and additional insight into how parents are
remembering different kinds of vaccination events. This feedback was
leveraged to create a user-friendlymobile application. The reported val-
idation project was thus designed to assess the status quo and to test a
practical means for improving the status quo using a beta version of
the VAccApp. We are presenting the results of a validation study testing
the VAccApp in the typical user-group of parents waiting for their child
to be seen at a pediatric emergency room in Berlin, Germany. To the au-
thor’'s knowledge no similar educational tools have been developed so
far. Different applications and textmessage services for appointment re-
minders have shown promising results in increasing the vaccination
rate among users but did not test the knowledge of parents regarding
the vaccination status of their children (Oyo-Ita et al., 2011; Stockwell
et al., 2012; Wakadha et al., 2013).2. Methods
2.1. Participants
The validation project was conducted from March 2012–August
2014 in the context of quality management (QM) programs at the
Charité Department of Pediatrics in collaboration with the Robert
Koch Institute in Berlin, Germany, as described previously (Rath et al.,
2013; Chen et al., 2014; Karsch et al., 2015; Obermeier et al., 2016;
Tief et al., 2016). Infants and children (0–18 years of age) presenting
to the ED or hospitalized with suspected vaccine-preventable diseases
(e.g. influenza-like illness or infections of the central nervous system)
participated in QM programs approved by the institutional review
board (IRB, EA24/008/10, EA2/161/11). Their parents were eligible forVAccApp user-testing. Informed consent procedures were waived by
the IRB for the purpose of quality improvement.
2.2. Standard operating procedure (SOP)
According to the QM SOP, vaccination recordswere solicited from all
patients participating in the QM program. When the WHO-ICV was
available, a photocopy was obtained for manual data entry into an
anonymized PostgreSQL database, performed by an independent data
entry professional, followed by double-entry verification (gold
standard).
When vaccination records were not available (in approximately 74%
of cases) trained QM staff conducted structured interviews, asking
the parents about the vaccination status for every VPD separately (i.e.
“Was your child ever vaccinated against rotavirus?” — Yes/No/I do
not know). After completion of the interview, parents were asked to
hand in the WHO-ICV later, for a photocopy and professional data
entry (“Recall Group”).
From January 2014–August 2014, those parents who were fluent in
German and who had brought their WHO-ICV with them, were invited
to transfer the information (as they understood it) from the WHO-ICV
into the VAccApp (“VAccApp Group”).
Professional data entry from the same vaccination record served as
the gold standard for the quality of data obtained with the VAccApp.
Likewise, the quality of data obtained from verbal immunization histo-
ries in the absence of a vaccination record was compared to the gold
standard, i.e. professional data entry froma vaccination record later pro-
vided by the parents.
Both the structured interview as well as the VAccApp solicited the
same basic information regarding 25 different vaccine types.
TheVAccApp also contained a brief pre/post testing feature, assessing
potential short-term learning effects resulting from VAccApp utilization:
Initially, participantswere asked to remember off-record, whether their
child had ever received any of three commonly used childhood immuni-
zations. The same question was repeated immediately after VAccApp
utilization. The pre/post testing had to be completedwithout consulting
the WHO-ICV or the VAccApp.
After using the VAccApp, parents were also invited to provide a feed-
back regarding the mobile application itself, using a standard instru-
ment, the so-called System Usability Scale (Brooke, 1996; Bangor et
al., 2008). The System Usability Score consists of ten statements (e.g.
“I felt very confident using the app”), which are judged by the user on
a five point Likert scale. Scores are reported ranging from 0 (“worst
imaginable”) to 100 (“best imaginable”) (Brooke, 1996; Bangor et al.,
2008).
2.3. VAccApp design
The VAccApp was designed to help parents understand the vaccina-
tion record of their children. The mobile application was developed by
ViVI, a Berlin-based vaccine safety think tank and non-profit organiza-
tion, in collaboration with the School of Design Thinking in Potsdam,
Germany (Seeber et al., 2015). Design Thinking is an innovation tech-
nique first taught at Stanford University with a strong focus on user-
centeredness and interdisciplinary thought processes (MacFadyen,
2014). The visual language of the VAccApp is non-threatening and play-
ful, using graphical representations of health care practitioners and vac-
cine recipients (avatars) keeping the user engaged.
For the purposes of the QM program, the VAccApp beta version was
provided onGoogle Nexus 7 Tablets™ as amobile application for Android
systems (Seeber et al., 2015). During the evaluation period, the VAccApp
remained on the tablet computers provided by QM staff. Parents en-
tered the requested information autonomously and anonymously
while waiting for their child to be seen by a doctor.
When using the VAccApp, parents were instructed to open the vacci-








Age of the child
(mean in months) range
38.7 82.1 b0.001
(2180) (2216)
Gender (% male) 56.2 49.3 0.151
First or second generation international migrant (%) 51.1 52.9 0.708
Race (%) Caucasian or White 83.1 75.2 0.046
Middle Eastern or North African 10.1 13.7 0.254
African American or Black 2.2 3.2 0.529
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representing either a physician or a nurse, asking for example “Is your
child vaccinated against tetanus?” (Fig. 1)
After the initial yes/no/unknown response, the avatar assisted the
user in localizing pertinent information in theWHO-ICV and on product
labels. Parents could also enter the name and number of immunizations
received, including booster vaccinations, batch numbers, and vaccina-
tion dates. The queries were repeated for every vaccine type separately
(named after the respective VPD), including special indication and trav-
el vaccines.Asian 2.2 2.5 0.838
Native Hawaiian or other Pacific
Islander
0.0 0.4 0.399
Other 0.6 0.7 0.898
Unidentified 1.7 4.3 0.129
Ethnicity (%) Hispanic or Latino 1.1 0.7 0.651
Non-Hispanic or Latino 96.6 92.1 0.051
Other 1.1 2.2 0.385
Unidentified 1.1 5.0 0.027
Number of individuals living in household (mean) 3.7 3.9 0.140
Birth rank of the child among siblings (mean) 1.6 1.7 0.501
Baseline characteristics of patients in theVAccAppGroup (n=178) compared to theRecall
Group (n = 278). p-Values were computed using the Whitney U test and the Chi-square
test to assesswhether the groupswere significantly different from each other. Boldface in-
dicates statistical significance (p b 0.05). The evaluation project was conducted between
2012 and 2014 in Berlin, Germany.2.4. Statistical analysis
Descriptive analyses were executed usingMicrosoft Excel 14.0.7 and
basic statistical analyses with IBM SPSS Statistics 22.
Table 1 illustrates the demographic characteristics of patients partic-
ipating in the VAccApp Group compared to the Recall Group. P-values
were computed using theWhitney U test and the Chi-square test to as-
sess whether the groups were significantly different from each other.
Responses from the structured interview and VAccApp entries were
both compared to gold standard, i.e. professional data entry fromphoto-
copies of the respectiveWHO-ICV. Bivariate statistical analysis was per-
formed, assessing the percentage of parents able to provide a complete
vaccination history (i.e. with 25/25 correct answers) in either group
(VAccApp and Recall Group).Fig. 1. Example of the VAccApp user interface.Overall accuracy rates were expressed as the percentage of the 25
vaccine questions in the VAccApp or structured interview, which a par-
ent had been able to answer correctly.
In addition, vaccine-specific accuracy rates were computed for each
vaccine type separately, and expressed as the proportion of parents pro-
viding accurate responses with either the VAccApp or during structured
interviews.
For the pre/post testing, the percentage of accurate responses before
and after VAccApp utilization was compared using the Chi-square test.
3. Results
3.1. Baseline characteristics
464 parents had initially brought the vaccination record with them.
Of these, 178 parents participated in the program, completing the user-
testing of theVAccApp (VAccAppGroup). Ten parents declined participa-
tion. The remaining 276 parents were unable to participate in the user-
testing due to lack of time or language skills.
A total of 278 parents did not have the vaccination record initially
butwere able to provide it at a later time (Recall Group) for comparison
between parental recall and the same gold standard (professional data
entry).
The composition of the VAccApp Group and the Recall Group is de-
scribed in detail in Table 1. The two groups differed significantlywith re-
spect to mean patient age and ethnicity: children in the VAccApp Group
were younger, andmore participants in the VAccAppGroup identified as
Caucasian (p b 0.001 and p=0.048, respectively). The remaining base-
line characteristics were comparable between groups.
3.2. Overall and vaccine-specific accuracy rates in the Recall Group
HavingnoWHO-ICV at hand, 9.0%of parents in theRecall Group pro-
vided a complete and fully accurate vaccination status (responding to
25/25 questions correctly). On average, 39.2% of the questions were an-
swered correctly. Additional detail was not requested in the Recall
Group. The majority of parents in the Recall Group (82.7%) indicated
that their children were up-to-date on recommended immunizations,
but when asked to respond to vaccine-specific questions, 41.7% parents
responded with “I do not know” to at least 24 out of 25 vaccine
Table 2
Vaccine-specific accuracy rates in the Recall Group.
Vaccine type
Accurate responses in
the Recall Group (%)



























Vaccine-specific accuracy rates describe the percentage of parents providing accurate vac-
cine-specific responses by recall only, i.e. without the vaccination record at hand (n =
278). Professional data entry from the original vaccination record served as gold standard.
RSV = respiratory syncytial virus (passive immunization).
Table 3
Vaccine-specific accuracy rates in the VAccApp Group.
Vaccine type
Accurate responses in
the VAccApp Group (%)



























Vaccine-specific accuracy rates describe the percentage of parents providing accurate vac-
cine-specific responses when entering data from the original vaccination record into the
VAccApp (n = 178). Professional data entry from the original vaccination record served
as gold standard. RSV = respiratory syncytial virus (passive immunization).
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from 23.7% for meningococcal vaccine to 69.1% for influenza.
3.3. Overall accuracy rates and vaccine-specific accuracy rates in the
VAccApp Group
With the help of the VAccApp and the vaccination record, 61.8% of
participants were able to provide a fully accurate vaccination status.
An average of 24/25 (95.2%) accurate responses was achieved. When
asked to provide additional detail, such as the number of vaccine
doses administered and the dates of administration, accuracy rates de-
clined progressively, but 25% of VAccApp users were able to provide all
additional detail accurately. Vaccine-specific accuracy rates ranged
from 85.4% for meningococcal vaccine to 100% for special indication
and travel vaccines such as cholera, typhoid fever, rabies and Japanese
encephalitis vaccines (Table 3).
3.4. Learning effects and usability score
The pre/post testing revealed a significant short-term learning effect
as illustrated in Fig. 2.
Prior to VAccApp utilization and without looking at the WHO-ICV,
24.7% of parents (44/178) were able to answer all three sample ques-
tions correctly, compared to 63.5% after VAccApp utilization
(p b 0.0001). System Usability Scores ranged from 35 to the maxi-
mum score of 100, with an average score of 69.6 (Table 4).
4. Discussion
Vaccines are powerful tools for disease prevention (Cherian and
Okwo-Bele, 2014). With vaccine hesitancy on the rise, parents are seek-
ing reliable information helping them to distinguish fact from fiction
(Downs et al., 2008; Strelitz et al., 2015). The active involvement ofparents in matters of vaccine prevention may contribute towards re-
storing trust (Oyo-Ita et al., 2011; Fadda et al., 2015; Odone et al.,
2015). Many parents have difficulties recalling the vaccination status
of their child, whichwas shownby several studies earlier and confirmed
by the current evaluation (Miles et al., 2013; McVicar, 2013). Parents
need encouragement and support when keeping track of the vaccina-
tion record of their children (Thorpe et al., 2016; Varkey et al., 2010).
This may be particularly important in larger families with many chil-
dren (Byington et al., 2015; Monto et al., 2014; Pearce et al., 2015;
Amin et al., 2013; Oliveira et al., 2014). Current vaccination records
however, are not designed to be used or understood by lay people.
Technical innovation may help parents to understand the vaccina-
tion status of their children. The VAccApp guides parents through the
paper record allowing them to store the data for themselves in an easily
accessible format. In this validation study, the App was user-tested by
parents who were waiting for their child to be seen at an academic
children's hospital in Germany. Use of the VAccApp motivated parents
to take a closer look at the vaccination record of their children, often
for the first time. It may be encouraging to doctors and patients alike,
that VAccApp users were able to complete 95% of vaccine questions in
the App correctly. A total of 62% responded to 100% of the questions cor-
rectly, thereby providing a complete and accurate vaccination history.
These results indicate that with the help of the WHO-ICV and the
VAccApp, the majority of parents are able to understand and interpret
the vaccination history of their children accurately.
The reported validation project aims to test the functionality and
feasibility of the VAccApp in a typical user group, with the limitation of
a convenience sample derived from a single center. The QM project
was not designed or powered to assess differences between subpopula-
tions. It is possible that parents who remembered to bring the vaccina-
tion records to the emergency room also showed a greater interest in
keeping their child's vaccinations up to date. Using the VAccAppwill al-
ways require a minimum level of interest in the topic of vaccines and
Fig. 2. Pre/post testing illustrating short-term learning effects. Short-term learning effects are illustrated before and immediately after use of the VAccApp: pre/post testing questions are
displayed separately with regards to tetanus, Haemophilus influenzae type b, and hexavalent vaccine.
Table 4
Results of the system usability assessment.
System Usability Scale
Mean value on Likert scale
(1-strongly disagree;
5-strongly agree)
#1: I think that I would like to use this app frequently. 3.57
#2: I found the app unnecessarily complex. 2.29
#3: I thought the app was easy to use. 3.89
#4: I think that I would need the support of a technical
person to be able to use this app.
1.87
#5: I found the various functions in this app were well
integrated.
3.70
#6: I thought there was too much inconsistency in
this app.
2.03
#7: I would imagine that most people would learn to
use this app very quickly.
3.41
#8: I found the app very cumbersome to use. 2.48
#9: I felt very confident using the app. 3.74
#10: I needed to learn a lot of things before I could get
going with this app.
1.81
After using the VAccApp for the first time, users were asked to assess the usability of the
VAccApp, using the System Usability Scale (Brooke, 1996; Bangor et al., 2008). The assess-
ment resulted in an overall SystemUsability Score of 69.5 out of possible 100 points, indi-
vidual scores ranging between 35 and 100.
245L. Seeber et al. / Preventive Medicine Reports 5 (2017) 241–250immunization. The VAccAppwas decisively not designed as a substitute
vaccination record, but as a helpful tool and encouragement for parents
to take an active part in keeping their children healthy. Since the valida-
tion study was embedded in a QM program, randomization was not
possible. Evidently, those parents who did not bring the vaccination re-
cordwith them, could not have been asked to enter data from an absent
vaccination record. Instead, they proceeded with verbal immunization
histories as per standard of care.
The goal of this study was to study the ability of parents to under-
stand the content of a standard vaccination record with the help of a
mobile application. The results were compared to professional data
entry into a standard clinical database using a copy of the same vaccina-
tion record.
The Recall Group served as a reminder that the quality of the infor-
mation gained with verbal immunization histories (which are common
practice) is in fact, very low. Minor demographic differences were ob-
served: VAccApp users had younger children on average compared to
the Recall Group. Younger children are vaccinated frequently, thus par-
ents may be more likely to remember bringing the vaccination record
with them to a doctor's visit.
The VAccApp can provide an important service with reminders for
booster immunizations andmotivatingparents to remainwell informed
246 L. Seeber et al. / Preventive Medicine Reports 5 (2017) 241–250about the vaccination status of their children. The visual clues of theApp
help parents to seewhere they are in the process, to keep appointments
and to prevent unnecessary delays in immunizations (Hofstetter et al.,
2015; Jordan et al., 2015; Uddin et al., 2016; Schlumberger et al.,
2015). At the same time parents generate important information to beFig. 3. TheWHO International Certificate of Vaccination or Prophylaxis (WHO-ICV). Routine chi
vaccinations (such as hepatitis A vaccine) are documented in a list format (b), which appearsstored on their smartphones, which may be helpful at any time when
the vaccination record may not be at hand. In the future, it will be im-
portant to engage older children and adolescents to learn more about
their own health and vaccination status. Future studies evaluating the
VAccApp in schools or adolescent clinics are currently being developed.ldhood vaccines (such as poliomyelitis vaccine) are presented in amatrix format (a). Other
to be more difficult for parents to read.
Fig. 3 (continued).
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ous settings, geographic regions and population strata, are planned. For
those using regular telephones rather than smartphones, the VAccApp
could be made available online for password-protected data entry via
short message service or public computers.
While itwould always be recommended for parents to bring the vac-
cination record to the hospital, this was the case in only 26% of parents
in our setting. In Europe, parents may not be aware of their responsibly
in this regard, unless their pediatrician has encouraged them to get in-
volved in keeping vaccinations up-to-date.
In our validation setting, parents in the Recall Groupweremost like-
ly to remember travel and special indication vaccines. This may be due
to the fact that “exotic” vaccines require active decision-making on be-
half of theparent, for example prior to taking a vacation in an exotic des-
tination (Bouder, 2015; Grimaldi-Bensouda et al., 2013; Daum et al.,
1995; Betsch et al., 2012; Hagen et al., 2008).
If the vaccination status was requested consistently during every
doctor's visit, parents would grow accustomed to taking the vaccination
record with them, including in stressful situations. This is evident from
the ability of parents to remember the tetanus vaccination status better
than other routine childhood vaccines, possibly due to the ‘positive rein-
forcement’ and frequent questioning by surgeons (Hagen et al. 2008).
Parents in this validation setting responded to vaccine-related questions
while waiting for their children to be seen in the pediatric ED. This is
also the “natural” setting where immunization data are relevant and
when parents are likely to be motivated to learn about the vaccines
protecting their children.
In many countries including in the US, the responsibility of main-
taining vaccination records remains with the physician, the school sys-
tem, or public health institutions, as would be the case with national or
regional vaccination registries (Miles et al., 2013; Maurer et al., 2014;Dombkowski et al., 2014). Parents who are interested to create their
own, portable vaccination record for their children, may take photos
of the vaccination record to keep it in their smartphones.
While the accuracy of vaccination data may be higher with this ap-
proach, the VAccApp project was intentionally designed to empower
parents to keep track of vaccinations in their family and to ask clarifying
questions during the doctor's visit, rather than delegating the entire task
to the healthcare provider (Seeber et al., 2015).
The design of the VAccAppwas a strength, as it was assessed by par-
ents in the System Usability Survey. This may be due to an appealing
user surface and the interaction with avatars. Completing the record
in the VAccApp for the first time can be time consuming, as it required
around 30min. The timemaybe readily available andwell-spent during
waiting hours in the ED. Future vaccinations can be added later within a
few minutes. Parents will be able to create one vaccine and risk factor
profile per child, which can be linked through a common login for the
entire family. Currently, the VAccApp assesses the vaccination status
for 25 different vaccines, updates will be necessary for newly recom-
mended vaccines. The VAccApp is available in German language, and
translation into multiple additional languages is underway. The
VAccApp will also need to be adjusted to accommodate different vacci-
nation schedules across Europe and beyond.
The VAccApp validation provides useful insight on how the accuracy
rate of 62% could be improved further: Routine childhood vaccination
data are usually provided in a matrix format in the WHO-ICV (Fig. 3a),
which appeared self-explanatory to most parents. Pages in the WHO-
ICV where vaccines were listed individually (meningococcal vaccines
for example, see Fig. 3b; Table 3) were more likely to induce errors.
Additional guidance may be helpful. Future versions will provide
“need clarification” signifiers reminding the parent to ask clarifying
questions during upcoming physician visits, thereby improving data
248 L. Seeber et al. / Preventive Medicine Reports 5 (2017) 241–250quality over time (Hostetter and Klein, 2016). The learning effect with
the initial version of the VAccApp showed promise for future
developments.
The VAccApp is in full compliance with Clinical Data Interchange
Standards Consortium (CDISC) data standards, including the Clinical
Data Acquisition Standards Harmonization (CDASH), the Biomedical
Research Integrated Domain Group (BRIDG) Model and the Study
Data Tabulation Model (SDTM), thereby meeting regulatory require-
ments (Maurer et al., 2014; Souza et al., 2007; Fridsma et al., 2008;
Hill et al., 2015; Censi et al., 2015). This will be useful if VAccApp entries
are used in clinical trials, as well as safety and effectiveness studies. It
also ensures Health Insurance Portability and Accountability Act
(HIPPAA) compliance and data interoperability (Maurer et al., 2014;
Free et al., 2013; Brown et al., 2014; Atkinson et al., 2015; Gates
Foundation, 2016). Eventually, the user should be able to choosewheth-
er data are stored locally on the personal device or saved in a cloud sys-
tem, if so desired (Burgess et al., 2016).
Several vaccine-related mobile applications are under development,
e.g. the “Vaccine Record for Travellers“ in Australia (Mills, 2016),
“ImmunizeCA” in Canada (Canadian Public Health Association, 2016;
Wilson et al., 2015; Atkinson et al., 2016), and “myViavac” in Switzer-
land (Stiftung meineimpfungen, 2016). The majority of these applica-
tions issue reminders for immunization appointments (e.g. “Save The
Date” (NSW Ministry of Health, 2016), “Vaximate” (Pfizer Australia,
2016)), or provide vaccine information (e.g. “Shots Immunizations”
(Society of Teachers of Family Medicine (STFM), 2016), “Vaccines on
the go” (Vaccine Education Center at The Children's Hospital of
Philadelphia (VEC), 2016)).
The VAccApp has an entirely different focus and represents the first
user-centered education and empowerment tool allowing parents to
understand the content of the vaccination record in addition to storing
the data in a safe place. Well-informed parents who support and main-
tain vaccination records will have an improved sense of control and the
ratification of playing an active role in keeping their children healthy
(Fadda et al., 2015; Thorpe et al., 2016; Varkey et al., 2010; Kundi et
al., 2015). Parents, who have an active interest in vaccinations, will like-
ly encourage their peers to do the same, thereby improving public
knowledge and appreciation of immunization programs (Yeung et al.,
2016; Gargano et al., 2015).
5. Conclusions
Informed parents are more likely to appreciate the benefits of vac-
cines. With patient-reported outcomes becoming increasingly relevant
to regulators, user-centered mobile applications may help to shift the
attention to the vaccine recipient. The learning effect of digital vaccina-
tion apps could be further improved by providing additional feedback-
loops for vaccine follow-ups this generating additional data sources
for the monitoring of vaccine safety in real-time (Lindemann et al.,
2016; Panatto et al., 2016). With children and adolescents representing
the next generation of parents and caretakers, itwill be important to de-
velop age-appropriate forms of vaccine communication (Lee et al.,
2016). Digital vaccination records will be easily accessible to adoles-
cents and young adults, who rarely seek physician appointments
(Stockwell et al., 2012; Wakadha et al., 2013; Johnson et al., 2008;
Kharbanda et al., 2011; Castano et al., 2013; Amicizia et al., 2013). Inno-
vative visual language, based on gender and ethnic equality, is key to pa-
tient-driven vaccine communication.
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